Skip to main content
Equibles

NVS · Novartis AG · Metrics

Track NVS — free

Use NVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$140.77 -4.94 (-3.39%)
Rebalance outlook locked
Market Cap
$276.48B
Shares
1.90B
Volume · Sep 30 3.06M Avg daily vol (3M) 1.93M

NVS metrics

54 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$145.71
Market cap
$276.48B

Price action

20 metrics
Price change (1W)
+3.1%
Price change (30D)
-4.2%
Price change (3M)
-7.0%
Price change (6M)
-4.6%
Price change (YTD)
+5.7%
Price change (1Y)
+17.4%
Trailing year
Price change (5Y)
+75.8%
52-week high
$168.62
52-week low
$121.80
Change from 52-week high
-13.6%
Change from 52-week low
+19.6%
Annualized volatility
26.8%
Annualized volatility (3M)
37.5%
Beta
0.4
RSI (14D)
48.5
Price vs SMA 50
-3.7%
Price vs SMA 200
-3.3%
Avg volume (3M)
1.93M
Relative volume
0.8
Average dollar volume
$291.08M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.90B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
6.0
reciprocal yield 16.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-12-31

Profitability

9 metrics
Gross margin
78.8%
Operating margin
32.4%
Trailing 12 months
Net margin
25.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$24.18

Growth

11 metrics
Revenue growth YoY
+8.4%
Year over year
Net income growth YoY
+24.5%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+29.6%
Shares change YoY
-3.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+31.1%
EPS CAGR (5Y)
+15.2%
FCF CAGR (3Y)
+9.7%
FCF CAGR (5Y)
+7.3%

Quality

14 metrics
Return on equity
30.3%
Return on assets
12.6%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$11.59B
Latest balance sheet
Cash & equivalents
$11.44B
Total assets
$110.95B
Total debt
$29.60B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
1,639
13F filer change QoQ
+25
Institutional ownership
7.5%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 1.5 days to cover
Days to cover
1.5d
Short-squeeze score
32 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1114448 CUSIP 66987V109 13F (30d) 36 filings 20 filers Visit website Investor relations